Tag: Humira

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Humira

Sir Dai Rees obituary

Added to Collection on: 2021-07-25 16:30:00

Tags for this article:

Medical Research Council
Science and technology in the United Kingdom
Drugs
Articles
Branches of biology
LifeArc
Technology transfer
National Institute for Medical Research
Centre for Protein Engineering
Cambridge Antibody Technology
Adalimumab
MRC Laboratory of Molecular Biology
Humira
Dai David Allan Rees

Click the tags to see associated articles and topics

View Article Details
Acelyrin Wants to Move LA Biotech Beyond the 'Innovate and Exit' Model - dot.LA

Added to Collection on: 2021-11-16 19:47:18

Tags for this article:

Drugs
Health sciences
Health care
Adalimumab
Immunosuppressants
Amgen
Pharmaceutical industry
Humira
Shao-Lee Lin

Click the tags to see associated articles and topics

View Article Details
As Congress weighs drug price restraints, ICER calls out 'unsupported' increases | BioPharma Dive

Added to Collection on: 2021-11-16 17:53:19

Tags for this article:

Life Sciences
Health care
Health sciences
Pharmaceuticals policy
Health care management
Institute for Clinical and Economic Review
Biotechnology
Drugs
Healthcare reform in the United States
Adalimumab
Biosimilar
Pharmaceutical industry
Humira
United States

Click the tags to see associated articles and topics

View Article Details
7 Quality Dividend Stocks to Buy on the Dip | InvestorPlace

Added to Collection on: 2022-05-21 21:04:40

Tags for this article:

Finance
Money
Financial markets
Financial ratios
Dividends
Equity securities
Corporate finance
Stock market
Dividend yield
AbbVie
Stock
S&P 500 Dividend Aristocrats
Humira
Ukraine
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
The Three 'Kings' of High Dividend Yield - RealMoney - TheStreet

Added to Collection on: 2022-08-20 23:01:47

Tags for this article:

Financial ratios
Finance
Economy
Money
Dividend payout ratio
Dividends
Share repurchase
Adalimumab
Dividend yield
Dividend policy
Humira

Click the tags to see associated articles and topics

View Article Details
How Far Will AbbVie's Humira Revenue Fall in 2023? - TheStreet

Added to Collection on: 2022-10-02 02:39:17

Tags for this article:

Life Sciences
Articles
Companies
Monoclonal antibodies
Biotechnology
Adalimumab
Immunosuppressants
RTT
Biosimilar
AbbVie Inc.
Generic drug
Allergan
AbbVie
Humira

Click the tags to see associated articles and topics

View Article Details
The Humira patent thicket, the Noerr–Pennington doctrine and antitrust's patent problem

Added to Collection on: 2022-12-07 17:30:51

Tags for this article:

Medical specialties
Medicine
Drugs
RTT
Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Adalimumab
AbbVie Inc.
Ulcerative colitis
Arthritis
John McCafferty
Humira

Click the tags to see associated articles and topics

View Article Details
Alvotech deal could heighten biosimilar pressure on Humira - BioPharma Dive

Added to Collection on: 2024-04-19 16:31:12

Tags for this article:

Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Biopharmaceuticals
Biosimilar
Adalimumab
AbbVie
Sandoz
Pharmacy benefit management
Teva Pharmaceuticals
CVS Health
Humira
United States

Click the tags to see associated articles and topics

View Article Details
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

Added to Collection on: 2024-04-26 15:18:18

Tags for this article:

Specialty drugs
Accredo
Biopharmaceuticals
Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Adalimumab
Biosimilar
Express Scripts
Pharmacist
Pharmacy
Copayment
Humira

Click the tags to see associated articles and topics

View Article Details
Street View: AbbVie's Humira to be key debate through 2025 - TradingView

Added to Collection on: 2024-04-29 10:47:29

Tags for this article:

Immunosuppressants
AbbVie
Adalimumab
Biosimilar
United States
Humira
BOFA GLOBAL

Click the tags to see associated articles and topics

View Article Details